In AFPGC, miR-122-5p suppressed apoptosis and accelerated tumor growth via targeting Forkhead box O3 (FOXO3), suggesting that miR-122-5p may be a potential therapeutic target in AFPGC [28]. The gene discussed is FOXO3; the disease is neoplasm.